RodTurner's blog Latest Regulation A+ developments: In June of 2015, Title IV of the JOBS Act opened the door for everyone, everywhere, to start investing in private companies in the growth stage. Regulation A+, ...
Administrator's blog People battling cancer know that often the treatment can be worse than the actual disease. Chemotherapy, radiation, and even some natural therapies put the body through a lot in the name ...
Administrator's blog Manhattan Street Capital CEO Rod Turner was recently interviewed by Michael Lipkin of the San Diego Business Journal about the advantages to Regulation A+ funding and why the new route has ...
RodTurner's blog Muscle Maker, Inc. Reg A+ IPO Raising $20 mill at $51 mill pre-money valuation, plans to List on the NYSE in January. Underwritten by Tripoint. Muscle Maker Grill is a leading healthy fast-casual ...
RodTurner's blog Genprex (S-1 IPO) expects to list on the NASDAQ on Friday March 16 th- two days left. Their Oncoprex medicine delivers DNA to lung cancer cells via custom nanoparticles and causes low ...
RodTurner's blog Join Rod Turner and three more expert speakers for an informal discussion about Regulation A+ (a new way for investors to invest in private companies) for an informal happy hour on March 15th ...
support_13878's blog How to Become an Accredited Investor The Holy Grail of the investor, can be becoming an Accredited Investor and having all doors open for you to multiply your money. If this is your goal, ...
Rod Turner's blog Reg A+ offerings- Anyone can invest CalTier Reality - Multi-Family and Commercial Real Estate Investment Fund A diversified real estate portfolio for investors. Multi-Family properties ...
Rod Turner's blog New and Updated Offerings live on Manhattan Street Capital ERC Homebuilders Investors in ERC Homebuilders receive an 8% per annum dividend, paid monthly from the date of investment ...
RodTurner's blog Genprex is raising capital through their IPO to progress Clinical trials for their Gene Therapy lung cancer treatment. Genprex has developed Oncoprex, a unique medicine that is delivered to lung ...
